Company Corline Biomedical AB

CLBIO

SE0006887451

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 08:26:06 2024-06-04 am EDT			5-day change	1st Jan Change
11 ^SEK	+0.46%		+2.80%	-26.17%

Apr. 30	Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 14	Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.

Number of employees: 13

SEK in Million	2022	Weight	2023	Weight	Delta
Heparin Based Solutions 100.0 %	24	100.0 %	25	100.0 %	+6.28%

SEK in Million	2022	Weight	2023	Weight	Delta
Sweden 100.0 %	24	100.0 %	25	100.0 %	+6.28%

Managers	Title	Age	Since
Lars Henrik Nittmar CEO	Chief Executive Officer	58	07-12-31
Gunnar Tufveson CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Fredrik Carlsson CTO	Chief Tech/Sci/R&D Officer	-	10-12-31
Magnus Nilsson BRD	Director/Board Member	68	20-11-17
Åsa Holm LAW	General Counsel	-	20-12-31

Members of the board	Title	Age	Since
Magnus Nilsson BRD	Director/Board Member	68	20-11-17
Lars Fredrik Sunnanväder BRD	Director/Board Member	-	04-12-31
Lars Adam Holger Dahlberg CHM	Chairman	51	04-12-31
Gunilla Anders Ekström BRD	Director/Board Member	66	16-12-31
Henrik Krook BRD	Director/Board Member	51	17-12-31
Tomas Lifvendahl BRD	Director/Board Member	-	21-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,490,819	9,707,353 ( 45.17 %)	0	45.17 %

Corline Biomedical AB

Lefflersgatan 5

754 50, Uppsala

+46 18 71 30 90

http://www.corline.com

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
CORLINE BIOMEDICAL AB	-26.17%	22.59M
KYOWA KIRIN CO. LTD.	+14.26%	9.15B
SK BIOPHARMACEUTICALS CO., LTD.	-13.94%	4.9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+48.58%	4.46B
YUHAN CORPORATION	+14.10%	4.09B
INDIVIOR PLC	+19.66%	2.49B
BETTA PHARMACEUTICALS CO., LTD.	-25.55%	2.17B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+18.39%	2.1B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-39.57%	1.89B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals